… searched PubMed for clinical trials, case studies, and … ocrelizumab, rituximab, and ofatumumab were identified as effective … could mean fewer medications and potentially less treatment burden, though … with limited randomized controlled trial data. Most studies …

… mAb approved for breast cancer treatment, inhibits the human epidermal … Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, … complement-dependent cytotoxicity of ofatumumab on chronic lymphocytic leukemia …

… based on available information. Arzerra (ofatumumab) Gazyva (obinutuzumab) Riabni (rituximab … zirconium cyclosilicate) Gastrointestinal disorders FDA determined that no action is … Sarclisa labeling Sprycel (dasatinib) Drug-induced liver injury The “Warnings …

… MS (nrSPMS).1 The drug acts on microglia, macrophages, … new therapies advancing through trials—particularly BTKis like tolebrutinib … agents like ocrelizumab and ofatumumab—with transforming care in … on novel multiple sclerosis treatments: from dismal defeat to …

… chair in the Department of Pharmaceutical and Health Economics at … getting their prescribed medication, such as drugs for relapsing-remitting … ; MA-DP, 43.3%), ofatumumab (PDP, 99.6%; MA- … out-of-pocket drug expenses. “Innovative new treatments have made it …

… rituximab, ocrelizumab, and ofatumumab, have proven highly effective … the success of these treatments in preventing relapses, … the pharmaceutical industry, or by traditional billion-dollar trials. … , to interrogate large medical databases, among others, …

… of 484 abbreviated new drug applications since the beginning … of treatment were eligible for enrollment on the trial.3 … a phase 2 trial (NCT02604511) from Dana-Farber Cancer Institute, in … ibrutinib (PCI-32765) versus ofatumumab in patients with relapsed or …

… Phase III clinical trials reached 33 … Therapeutics Inc., MediciNova Inc., MedDay Pharmaceuticals SAS, AB … multiple sclerosis treatment. These drugs target specific … Antibodies: Ocrelizumab, Rituximab, Ofatumumab, Ublituximab 2 Immunosuppressants: …

… 5 randomized, controlled trials, including the RESTONATE trial (NCT01578707).3 RESONATE … investigators randomized patients to treatment with ibrutinib or ofatumumab (Kesimpta), including … 47;/www.accessdata.fda.gov/drugsatfda_docs/appletter…

… ofatumumab.8–10 Notably, recent randomized controlled trials … of Inner Mongolia Medical University (Hohhot) … receipt of the treatment drug. This retrospective … treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial …